{"database": "lobbying", "table": "lobbying_activities", "rows": [[2511799, "f950f01f-5dd6-4049-99e9-11a3390c7702", "Q3", "HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA)", 28776, "HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)", 2020, "third_quarter", "PHA", "Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271)\nIssues related to ARCOS data and suspicious order record requirements and reporting \nImportation of Prescription Drugs (HR 447, HR 478, HR 1478, S 61, S 97, S 658, S 844, Public Law 108-173) \nImplementation of Public Law 113-54 (DSCSA) \nBlock, Report, And Suspend Suspicious Shipments Act of 2019 (HR 3878) \nDebarment Act (HR 4806)\nEnsuring Compliance Against Drug Diversion (HR 4812)\nSuspicious Order Identification Act of 2019 (S. 2686, HR 4814)", "Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 336505, 0, 0, "2020-10-16T16:07:42.640000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2511799"], "units": {}, "query_ms": 158.2721290178597, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}